Are we closer to selective immunotherapy for autoimmune diseases?
The discipline of immunotherapy has promised much in the restricted confines of the laboratory but, so far, has delivered little in the harsh reality of the clinic. At a recent conference to celebrate the opening of Roche Milano Ricerche*, the hopes, successes and failures in this complex field were presented for examination.
Lamont
A
A
Roche Research Centre, Welwyn Garden City, Herts, UK.
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008285:Major Histocompatibility Complex / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology